FDA Releases Guidance to Reduce Risk of Creutzfeldt-Jakob Disease Transmission via Blood and Blood Components

Summary

The US Food and Drug Administration has published a final guidance document providing recommendations to blood establishments to minimize the risk of transmitting Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease through blood and blood components, effective immediately.